Myriad Genetics, Inc. (MYGN)
F4Q12 Earnings Conference Call
August 14, 2012 4:30 PM ET
Rebecca Chambers – Director of Investor Relations
Peter D. Meldrum – President and Chief Executive Officer
Mark C. Capone – President, Myriad Genetic Laboratories
James S. Evans – Chief Financial Officer and Treasurer
Scott Gleason – Stephens Inc.
Jon Wood – Jefferies & Company, Inc.
Amanda Murphy - William Blair
Michael Yee - RBC Capital Markets
Joel - Goldman Sachs
Sean Rodriguez - Cowen & Company
Derik de Bruin - Bank of America
William Quirk - Piper Jaffray
Tycho Peterson – JPMorgan
Dan Leonard - Leerink Swann
Ladies and gentlemen, thank you for standing by. Welcome to the Myriad Genetics' 2012 Fourth Quarter and Fiscal year-end Earnings Call. During the presentation, all participants will be in a listen-only-mode. Afterwards, we will conduct the question-and-answer session. (Operator instructions). As a reminder, this conference is being recorded Tuesday, August 14, 2012.
I would now like to turn the conference over to Rebecca Chambers, Director of Investor Relations. Please go ahead.
Thank you, Susan. Good afternoon, everyone, and welcome to the Myriad Genetics' fourth quarter and fiscal year 2012 earnings call. During the call, we will review the financial results we've released today and detail our expectations for fiscal 2013, after which we will host the question-and-answer session. If you have not had a chance to review the earnings release, it can be found in the Investor Relations section of our website at Myriad.com.